MCDERMOTT REPRESENTS VALINOR PHARMA IN $250M SALE TO GRUNENTHAL
July 24, 2024
July 24, 2024
CHICAGO, Illinois, July 24 -- McDermott Will and Emery, a law firm, issued the following news release:
McDermott Will & Emery represented Valinor Pharma, LLC (Valinor), a pharmaceutical company focused on the commercialization of medicines, in a cross-border sale to Grunenthal, a German-based global leader in pain management and related diseases.
The total deal value is approximately $250 million inclusive of all royalty obligations and includes Valinor's produ . . .
McDermott Will & Emery represented Valinor Pharma, LLC (Valinor), a pharmaceutical company focused on the commercialization of medicines, in a cross-border sale to Grunenthal, a German-based global leader in pain management and related diseases.
The total deal value is approximately $250 million inclusive of all royalty obligations and includes Valinor's produ . . .